Esophageal achalasia: current diagnosis and treatment

Expert Rev Gastroenterol Hepatol. 2018 Jul;12(7):711-721. doi: 10.1080/17474124.2018.1481748. Epub 2018 Jun 8.

Abstract

Esophageal achalasia is a primary esophageal motility disorder of unknown origin, characterized by lack of peristalsis and by incomplete or absent relaxation of the lower esophageal sphincter in response to swallowing. The goal of treatment is to eliminate the functional obstruction at the level of the gastroesophageal junction. Areas covered: This comprehensive review will evaluate the current literature, illustrating the diagnostic evaluation and providing an evidence-based treatment algorithm for this disease. Expert commentary: Today, we have three very effective therapeutic modalities to treat patients with achalasia - pneumatic dilatation, peroral endoscopic myotomy, and laparoscopic Heller myotomy with fundoplication. Treatment should be tailored to the individual patient, in centers where a multidisciplinary approach is available. Esophageal resection should be considered as a last resort for patients who have failed prior therapeutic attempts.

Keywords: Dor fundoplication; Esophageal achalasia; Heller myotomy; dysphagia; esophageal manometry; per oral endoscopic myotomy; pneumatic dilatation.

Publication types

  • Review

MeSH terms

  • Algorithms
  • Clinical Decision-Making
  • Critical Pathways
  • Dilatation
  • Esophageal Achalasia / diagnosis*
  • Esophageal Achalasia / epidemiology
  • Esophageal Achalasia / physiopathology
  • Esophageal Achalasia / surgery*
  • Esophageal pH Monitoring
  • Esophagus / physiopathology
  • Esophagus / surgery*
  • Fundoplication* / adverse effects
  • Gastrointestinal Motility*
  • Heller Myotomy* / adverse effects
  • Humans
  • Laparoscopy* / adverse effects
  • Manometry
  • Predictive Value of Tests
  • Pressure
  • Treatment Outcome